These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 30826748)

  • 1. GABRP regulates chemokine signalling, macrophage recruitment and tumour progression in pancreatic cancer through tuning KCNN4-mediated Ca
    Jiang SH; Zhu LL; Zhang M; Li RK; Yang Q; Yan JY; Zhang C; Yang JY; Dong FY; Dai M; Hu LP; Li J; Li Q; Wang YH; Yang XM; Zhang YL; Nie HZ; Zhu L; Zhang XL; Tian GA; Zhang XX; Cao XY; Tao LY; Huang S; Jiang YS; Hua R; Qian Luo K; Gu JR; Sun YW; Hou S; Zhang ZG
    Gut; 2019 Nov; 68(11):1994-2006. PubMed ID: 30826748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit.
    Takehara A; Hosokawa M; Eguchi H; Ohigashi H; Ishikawa O; Nakamura Y; Nakagawa H
    Cancer Res; 2007 Oct; 67(20):9704-12. PubMed ID: 17942900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated expression profiling of potassium channels identifys KCNN4 as a prognostic biomarker of pancreatic cancer.
    Jiang S; Zhu L; Yang J; Hu L; Gu J; Xing X; Sun Y; Zhang Z
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):113-119. PubMed ID: 29050937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABRP promotes CD44s-mediated gemcitabine resistance in pancreatic cancer.
    Chen C; Wu B; Wang M; Chen J; Huang Z; Shi JS
    PeerJ; 2022; 10():e12728. PubMed ID: 35846884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased SPRY1 expression activates NF-κB signaling and promotes pancreatic cancer progression by recruiting neutrophils and macrophages through CXCL12-CXCR4 axis.
    Shi T; Li X; Zheng J; Duan Z; Ooi YY; Gao Y; Wang Q; Yang J; Wang L; Yao L
    Cell Oncol (Dordr); 2023 Aug; 46(4):969-985. PubMed ID: 37014552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer.
    Adamska A; Domenichini A; Capone E; Damiani V; Akkaya BG; Linton KJ; Di Sebastiano P; Chen X; Keeton AB; Ramirez-Alcantara V; Maxuitenko Y; Piazza GA; De Laurenzi V; Sala G; Falasca M
    J Exp Clin Cancer Res; 2019 Aug; 38(1):312. PubMed ID: 31378204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABRP Promotes the Metastasis of Pancreatic Cancer by Activation of the MEK/ERK Signaling Pathway.
    Meng Y; Li R; Geng S; Chen W; Jiang W; Li Z; Hao J; Xu Z
    Biochem Genet; 2024 Feb; 62(1):242-253. PubMed ID: 37326897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KCNN4-mediated Ca
    Mo X; Zhang CF; Xu P; Ding M; Ma ZJ; Sun Q; Liu Y; Bi HK; Guo X; Abdelatty A; Hu C; Xu HJ; Zhou GR; Jia YL; Xia HP
    Acta Pharmacol Sin; 2022 Mar; 43(3):735-746. PubMed ID: 34183755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXO1-regulated lncRNA LINC01197 inhibits pancreatic adenocarcinoma cell proliferation by restraining Wnt/β-catenin signaling.
    Ling J; Wang F; Liu C; Dong X; Xue Y; Jia X; Song W; Li Q
    J Exp Clin Cancer Res; 2019 Apr; 38(1):179. PubMed ID: 31027497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
    Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
    Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DYRK1A modulates c-MET in pancreatic ductal adenocarcinoma to drive tumour growth.
    Luna J; Boni J; Cuatrecasas M; Bofill-De Ros X; Núñez-Manchón E; Gironella M; Vaquero EC; Arbones ML; de la Luna S; Fillat C
    Gut; 2019 Aug; 68(8):1465-1476. PubMed ID: 30343272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duffy antigen receptor for chemokines (DARC) expressing in cancer cells inhibits tumor progression by suppressing CXCR2 signaling in human pancreatic ductal adenocarcinoma.
    Maeda S; Kuboki S; Nojima H; Shimizu H; Yoshitomi H; Furukawa K; Miyazaki M; Ohtsuka M
    Cytokine; 2017 Jul; 95():12-21. PubMed ID: 28214673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant epigenetic regulation of GABRP associates with aggressive phenotype of ovarian cancer.
    Sung HY; Yang SD; Ju W; Ahn JH
    Exp Mol Med; 2017 May; 49(5):e335. PubMed ID: 28524180
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Yang Y; Ren L; Li S; Zheng X; Liu J; Li W; Fu W; Wang J; Du G
    Transl Cancer Res; 2022 Apr; 11(4):649-668. PubMed ID: 35571651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions.
    Jiang Z; Zhou C; Cheng L; Yan B; Chen K; Chen X; Zong L; Lei J; Duan W; Xu Q; Li X; Wang Z; Ma Q; Ma J
    J Exp Clin Cancer Res; 2018 Mar; 37(1):69. PubMed ID: 29587800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VDR promotes pancreatic cancer progression in vivo by activating CCL20-mediated M2 polarization of tumor associated macrophage.
    Li H; Ruan Y; Liu C; Fan X; Yao Y; Dai Y; Song Y; Jiang D; Sun N; Jiao G; Chen Z; Fan S; Meng F; Yang H; Zhang Y; Li Z
    Cell Commun Signal; 2024 Apr; 22(1):224. PubMed ID: 38600588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.
    Grünwald B; Harant V; Schaten S; Frühschütz M; Spallek R; Höchst B; Stutzer K; Berchtold S; Erkan M; Prokopchuk O; Martignoni M; Esposito I; Heikenwalder M; Gupta A; Siveke J; Saftig P; Knolle P; Wohlleber D; Krüger A
    Gastroenterology; 2016 Nov; 151(5):1011-1024.e7. PubMed ID: 27506299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GABA A receptor π subunit promotes apoptosis of HTR-8/SVneo trophoblastic cells: Implications in preeclampsia.
    Lu J; Zhang Q; Tan D; Luo W; Zhao H; Ma J; Liang H; Tan Y
    Int J Mol Med; 2016 Jul; 38(1):105-12. PubMed ID: 27221053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
    Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
    Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis.
    Li X; Xiao Y; Fan S; Xiao M; Wang X; Chen X; Li C; Zong G; Zhou G; Wan C
    Exp Mol Pathol; 2016 Oct; 101(2):176-186. PubMed ID: 27498047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.